Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

Matejka Rebolj, Sarah Preisler, Ditte Møller Ejegod, Carsten Rygaard, Elsebeth Lynge, Jesper Bonde

71 Citationer (Scopus)

Abstract

WE AIMED TO DETERMINE THE DISAGREEMENT IN PRIMARY CERVICAL SCREENING BETWEEN FOUR HUMAN PAPILLOMAVIRUS ASSAYS: Hybrid Capture 2, cobas, CLART, and APTIMA. Material from 5,064 SurePath samples of women participating in routine cervical screening in Copenhagen, Denmark, was tested with the four assays. Positive agreement between the assays was measured as the conditional probability that the results of all compared assays were positive given that at least one assay returned a positive result. Of all 5,064 samples, 1,679 (33.2%) tested positive on at least one of the assays. Among these, 41% tested positive on all four. Agreement was lower in women aged ≥30 years (30%, vs. 49% at
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind9
Udgave nummer1
Sider (fra-til)e86835
Antal sider12
ISSN1932-6203
DOI
StatusUdgivet - 20 jan. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening'. Sammen danner de et unikt fingeraftryk.

Citationsformater